Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA greenlights first non-opioid treatment for severe pain in 20 years
Journavax was shown in clinical trials to be safe and effective, with no addictive potential.
PCI before TAVR linked to better outcomes than performing both at once
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
Swedish total artificial heart tech granted FDA’s humanitarian use designation
Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.
New findings prompt experts to call for routine brain imaging of certain breast cancer patients
New research suggests more women with late-stage breast cancer may develop brain metastases than previously believed.
Medical device company raises $36M for emitter-free IVL platform
Boston-based Amplitude Vascular Systems is busy investigating the performance of its Pulse IVL platform in a wide variety of patient populations.

Renal denervation is associated with improved blood pressure (BP) control and a reduced risk of adverse cardiovascular outcomes, according to two late-breaking clinical trials presented at EuroPCR 2022 in Paris. Both clinical trials focused on three-year data related to Medtronic’s Symplicity Spyral Renal Denervation (RDN) System, which was designed to lower BP through the use of a curling catheter that ablates overactive nerves.

Renal denervation improves blood pressure control, lowers risk of adverse cardiovascular outcomes

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.

Arterial stiffness may predict type 2 diabetes risk better than high blood pressure

Researchers tracked data from more than 11,000 adult patients, sharing their findings in Hypertension.

Cardiologists join the FDA’s fight against menthol cigarettes, flavored cigars

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

ACC.22 kicked off on Saturday, April 2, in Washington, D.C.

VIDEO: Key technology trends in cardiology, as seen at ACC.22

American College of Cardiology President Edward T. A. Fry, MD, discusses his general takeaways on technology advances seen during ACC.22.

Edward Fry, MD, is the 2022-23 ACC president.

VIDEO: ACC president shares his key takeaways from ACC 2022

American College of Cardiology (ACC) President Edward T. A. Fry, MD, of the Ascension St. Vincent Hospital in Indianapolis, discusses the first in-person ACC meeting in three years and the impact of COVID-19 on cardiology practice.

Medtronic’s more deliverable drug-eluting stent gains FDA approval

According to Medtronic, the Onyx Frontier DES features improved catheter flexibility and a lower crossing profile.

A key update: 1 year later, no signs of long-term heart damage among college athletes who had COVID-19

More than 3,500 college athletes with a confirmed COVID-19 diagnosis were included in the new study. The median follow-up period was more than one full year.

TAVR safe and effective for patients with mixed aortic valve disease

MAVD patients did face a higher risk of requiring a permanent pacemaker, researchers noted, though the reason for this trend remains unclear.

Clinical

FDA greenlights first non-opioid treatment for severe pain in 20 years

PCI before TAVR linked to better outcomes than performing both at once

Swedish total artificial heart tech granted FDA’s humanitarian use designation

New findings prompt experts to call for routine brain imaging of certain breast cancer patients

Medical device company raises $36M for emitter-free IVL platform